- Cefditoren
-
Cefditoren Systematic (IUPAC) name (7R)-7-((Z)-2-(2-Aminothiazol-4-yl)-2-(methoxyimino)acetamido)-3-((Z)-2-(4-methylthiazol-5-yl)vinyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid Clinical data Trade names Spectracef AHFS/Drugs.com monograph MedlinePlus a605003 Pregnancy cat. ? Legal status ? Identifiers CAS number 104145-95-1 ATC code J01DD16 PubChem CID 9870843 ChemSpider 8046534 UNII 81QS09V3YW KEGG D07639 ChEBI CHEBI:59343 Chemical data Formula C19H18N6O5S3 Mol. mass 506.58 g/mol SMILES eMolecules & PubChem (what is this?) (verify) Cefditoren is a third-generation cephalosporin antibiotic for oral use. It is commonly marketed under the trade name Spectracef by Cornerstone BioPharma.
Cefditoren is also marketed under the name Meiact.[1]
Contents
Clinical use
Main article: CephalosporinIndications
Cefditoren is used to treat uncomplicated skin and skin structure infections, community-acquired pneumonia, acute bacterial exacerbation of chronic bronchitis (ABECB), pharyngitis, and tonsillitis.
Formulations
Cefditoren is available as 200 and 400 mg tablets. It can be formulated as the prodrug cefditoren pivoxil.
References
External links
Categories:- Cephalosporin antibiotics
- Thiazoles
Wikimedia Foundation. 2010.